What is Alpha-Lipoic Acid?
Alpha-lipoic acid (ALA) is a naturally occurring antioxidant and mitochondrial cofactor—specifically a medium-chain fatty acid derived from linoleic acid—that functions both as an endogenously synthesized compound in human tissues and as a therapeutic agent available in oral and intravenous formulations. 1
Chemical and Biological Properties
ALA is a sulfur-containing organic compound derived from octanoic acid that serves as an essential cofactor for mitochondrial respiratory enzymes 2, 3. What makes ALA unique among antioxidants is its dual nature: it exists in both an oxidized form (ALA) and a reduced form (dihydrolipoic acid, DHLA), with both forms exhibiting potent antioxidant activity 2, 4.
The ALA/DHLA system is amphiphilic—meaning it is soluble in both water and fat—allowing it to function throughout all cellular compartments, unlike most antioxidants that are limited to either aqueous or lipid environments 2, 4. This property has earned ALA the designation as the "antioxidant of antioxidants" because it not only directly scavenges reactive oxygen species but also regenerates other antioxidants including vitamins C and E and glutathione 2.
Distinction from Alpha-Linolenic Acid
It is critical to note that alpha-lipoic acid (ALA) is completely different from alpha-linolenic acid (also abbreviated ALA), which is an omega-3 essential fatty acid found in plant sources like flaxseed, walnuts, and certain vegetable oils 5, 6, 7. The context of your question and the evidence provided indicates you are asking about alpha-lipoic acid (the antioxidant), not alpha-linolenic acid (the omega-3 fatty acid). These are entirely distinct compounds with different chemical structures, biological functions, and clinical applications.
Clinical Applications
Diabetic Neuropathy
The most robust clinical evidence supports ALA use for diabetic peripheral neuropathy, where 27 randomized controlled trials have demonstrated benefit 1. A meta-analysis confirmed that oral ALA dosing of 600 mg once daily is equivalent to intravenous infusions for reducing neuropathic pain 1. The evidence supports intravenous administration of 600 mg per day over a 3-week period for clinically meaningful improvement in positive neuropathic symptoms and deficits 8.
Chemotherapy-Induced Neuropathy
For prevention of chemotherapy-induced peripheral neuropathy (CIPN), ALA is NOT recommended 9. A randomized, double-blind trial evaluating 600 mg ALA three times daily for 24 weeks in patients receiving platinum-based chemotherapy showed no ameliorating effect, with only 29% of patients completing the trial due to poor tolerability from the three-times-daily dosing requirement 9.
Other Potential Applications
Research evidence suggests ALA may have beneficial effects in:
- Metabolic disorders and cardiovascular disease risk factors through blood lipid modulation and LDL oxidation protection 2, 10, 4
- Neurodegenerative conditions including Alzheimer's and Parkinson's diseases through mitochondrial function improvement 2, 10, 3, 11
- Kidney diseases through antioxidant and protective mechanisms 12
- Metal toxicity mitigation (aluminum, arsenic, lead, mercury, cadmium) through chelation and antioxidant properties 13
Safety Considerations
ALA has a relatively narrow therapeutic index compared to other vitamin supplements, and overdose can cause severe, life-threatening toxicity 14. Clinical studies have shown safety and tolerability at doses around 600 mg daily, but accidental ingestion of 6 grams has resulted in rapid onset of confusion, seizures, lactic acidosis, and respiratory failure requiring intubation 14. The clinical picture of ALA toxicity includes gastrointestinal symptoms, altered mental status, seizure activity unresponsive to standard anticonvulsants, and circulatory instability 14. No antidote exists; management is purely supportive 14.
Formulations and Dosing
Standard therapeutic dosing is 600 mg once daily, administered either orally or intravenously 1, 8. Injectable formulations demonstrate superior bioavailability in experimental settings, though most clinical use involves oral administration 10. The compound is available as a dietary supplement, though the FDA drug label evidence provided 15 appears to reference a homeopathic preparation rather than standard pharmaceutical ALA formulations.
Mechanism of Action
ALA combats oxidative stress through multiple mechanisms: direct quenching of reactive oxygen species, metal chelation, regeneration of other antioxidants, modulation of inflammatory pathways, and enhancement of mitochondrial respiratory enzyme function 2, 10, 12, 4. Its endogenous synthesis occurs in mitochondria via lipoic acid synthase, but production decreases with age, potentially contributing to age-related disorders 12, 11.